SEC Form 4 · accession 0000899243-17-018211
Inhibitor Therapeutics, Inc. · INTI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
HedgePath, LLC
10% Owner
Period of report
Jun 30, 2017
Accepted (ET)
Jul 12, 2017 · 4:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001042418
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $.0001 par value per shareF1 | Jun 30, 2017 | S$0 | 2,500,000 | — | D | 79,627,069 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1On June 30, 2017, the Reporting Person sold 2,500,000 shares of restricted common stock in a private transaction to an unaffiliated third party for a total purchase price of $500,000.